100 Participants Needed

Mindfulness Practices for ADHD

Recruiting at 1 trial location
MA
Overseen ByMatthew A Jarrett, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama, Tuscaloosa
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood and is associated with significant life impairments. The current study evaluates the feasibility, acceptability, and preliminary efficacy of a group-based mindfulness intervention for first-year college students with ADHD. If found to be feasible, acceptable, and efficacious, subsequent research will examine its impact on a larger scale to have a broader public health impact for college students with ADHD.

Do I need to stop my current medications for the trial?

The trial does not specify if you need to stop your current medications, but it mentions that participants should not have an unstable dosage of psychotropic medication (medications that affect mood, perception, or behavior). It might be best to discuss your current medication with the trial coordinators.

What data supports the effectiveness of this treatment for ADHD?

Research shows that mindfulness-based treatments, like Mindfulness-Based Cognitive Therapy (MBCT) and Mindful Awareness Practices (MAPs), can help reduce ADHD symptoms and improve mental health in adults. These therapies have shown promising results in improving attention and self-control, which are often challenging for people with ADHD.12345

Is mindfulness safe for people with ADHD?

Mindfulness practices, like Mindfulness-Based Cognitive Therapy (MBCT) and Mindful Awareness Practices (MAPs), have been studied for ADHD and are generally considered safe for adults and children. Some studies show they can help improve mental health and reduce ADHD symptoms, with only a modest drop-out rate, indicating they are well-tolerated.34567

How is the Mindfulness Awareness Practices treatment different from other ADHD treatments?

Mindfulness Awareness Practices for ADHD is unique because it focuses on improving attention and self-regulation through mindfulness meditation, which is a non-drug approach. This treatment helps individuals with ADHD by enhancing their ability to focus and manage emotions, offering an alternative or complement to traditional medication-based therapies.34589

Eligibility Criteria

This trial is for first-year college students aged 17-25 who have been diagnosed with ADHD. Participants should not have major medical issues or severe mental health conditions like depression, mania, substance abuse, personality disorders that could affect group participation, psychosis, recent trauma, or unstable psychotropic medication doses.

Inclusion Criteria

I am a first-semester college student with ADHD.
I am between 17 and 25 years old.
You meet the requirements for ADHD.
See 1 more

Exclusion Criteria

My mental health medication dose has been changing.
I have experienced symptoms like hallucinations or delusions.
Ongoing substance abuse
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo an 8-week, group-based mindfulness program (MAPs) for ADHD, delivered within university counseling center settings.

8 weeks
Weekly sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 1-month and 6-month post-treatment.

6 months

Treatment Details

Interventions

  • Mindfulness Awareness Practices for ADHD (adapted)
Trial OverviewThe study is testing a mindfulness program adapted for ADHD against the usual services provided to these students. It aims to see if this approach is practical and helpful in managing ADHD symptoms among first-year college students.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Adapted Mindful Awareness Practices (MAPS)Experimental Treatment1 Intervention
The Mindful Awareness Practices (MAPs) for ADHD program, an 8-week, group-based mindfulness program for adults with ADHD, has been shown to reduce ADHD, depression, and anxiety symptoms. While promising, it is unknown as to whether the MAPs protocol is feasible, acceptable, and efficacious for college students with ADHD. The current study takes the first step towards enhanced study of mindfulness for college students with ADHD by testing the feasibility, acceptability, and preliminary efficacy of an adapted MAPs protocol delivered within university counseling center settings during the first semester of college.
Group II: Services-As-UsualActive Control1 Intervention
Services-As-Usual includes the standard academic support services provided by university disability/accessibility offices.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama, Tuscaloosa

Lead Sponsor

Trials
49
Recruited
17,900+

Wofford College

Collaborator

Trials
1
Recruited
100+

Findings from Research

A 12-week mindfulness-based cognitive therapy (MBCT) program significantly reduced ADHD symptoms in adults, as shown by both investigator ratings and self-reports from 55 participants compared to a waitlist group of 48.
Improvements in executive functioning and mindfulness skills were also noted, suggesting that the effectiveness of MBCT may be linked to enhanced mindfulness, particularly the skill of 'Act With Awareness', although no changes were observed in depressive or anxiety symptoms.
The Efficacy of Adapted MBCT on Core Symptoms and Executive Functioning in Adults With ADHD: A Preliminary Randomized Controlled Trial.Hepark, S., Janssen, L., de Vries, A., et al.[2022]
An 8-week mindfulness training program (MAP) was found to be equally effective as structured psychoeducation (PE) in reducing ADHD symptoms among 81 medication-free adult patients, with both groups showing significant improvements that lasted for 6 months.
The study also suggested a potential gender difference in treatment response, with women benefiting more overall, while men showed greater improvements specifically under the mindfulness training.
Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial.Hoxhaj, E., Sadohara, C., Borel, P., et al.[2018]
An adapted Mindfulness-Based Cognitive Therapy (MBCT) program for adults with ADHD showed a significant reduction in ADHD symptoms and improvements in executive functioning, self-compassion, and mental health among 31 participants.
The study had a low drop-out rate of 16%, indicating that the program was feasible, but further research through a larger Randomized Controlled Trial (RCT) is necessary to confirm its effectiveness.
The Feasibility, Effectiveness, and Process of Change of Mindfulness-Based Cognitive Therapy for Adults With ADHD: A Mixed-Method Pilot Study.Janssen, L., de Vries, AM., Hepark, S., et al.[2022]

References

The Efficacy of Adapted MBCT on Core Symptoms and Executive Functioning in Adults With ADHD: A Preliminary Randomized Controlled Trial. [2022]
Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial. [2018]
The Feasibility, Effectiveness, and Process of Change of Mindfulness-Based Cognitive Therapy for Adults With ADHD: A Mixed-Method Pilot Study. [2022]
Mindfulness-based cognitive therapy v. treatment as usual in adults with ADHD: a multicentre, single-blind, randomised controlled trial. [2020]
Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions. [2022]
The Effectiveness of Mindfulness-Based Therapies for ADHD: A Meta-Analytic Review. [2021]
Effects of Mindfulness-Based Interventions in Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [2023]
Mindfulness training as an adjunct to evidence-based treatment for ADHD within families. [2022]
A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation. [2022]